Conventional genome-wide association studies (GWASs) of complex traits, such as Multiple Sclerosis (MS), are reliant on per-SNP p-values and are therefore heavily burdened by multiple testing correction. Thus, in order to detect more subtle alterations, ever increasing sample sizes are required, while ignoring potentially valuable information that is readily available in existing datasets. To overcome this, we used penalised regression incorporating elastic net with a stability selection method by iterative subsampling to detect the potential interaction of loci with MS risk. Through re-analysis of the ANZgene dataset (1617 cases and 1988 controls) and an IMSGC dataset as a replication cohort (1313 cases and 1458 controls), we identified ne...
Genome-wide association studies (GWASs) have proven highly effective, identifying hundreds of associ...
Genome-wide association studies (GWAS) have identified more than 50,000 unique associations with com...
Background: Multiple sclerosis (MS) is a complex trait in which genes in the MHC class II region ex...
Background: Population based genome wide association studies have identified 110 single nucleotide p...
Genome-wide association studies (GWAS) successfully identified various chromosomal regions to be ass...
Genome-wide association studies (GWAS) successfully identified various chromosomal regions to be ass...
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, with a comp...
Background: Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginn...
Genome-wide association studies (GWAS) have identified more than 50,000 unique associations with com...
AbstractMultiple sclerosis (MS) is characterized by inflammation, axonal and oligodendrocyte patholo...
A recent genome wide association study (GWAS) demonstrated that more than 100 genetic variants influ...
Genome-wide association studies (GWAS) have identified more than 50,000 unique associations with com...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Genome-wide association studies (GWAS) testing several hundred thousand SNPs have been performed in ...
Genome-wide association studies (GWASs) have proven highly effective, identifying hundreds of associ...
Genome-wide association studies (GWAS) have identified more than 50,000 unique associations with com...
Background: Multiple sclerosis (MS) is a complex trait in which genes in the MHC class II region ex...
Background: Population based genome wide association studies have identified 110 single nucleotide p...
Genome-wide association studies (GWAS) successfully identified various chromosomal regions to be ass...
Genome-wide association studies (GWAS) successfully identified various chromosomal regions to be ass...
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, with a comp...
Background: Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginn...
Genome-wide association studies (GWAS) have identified more than 50,000 unique associations with com...
AbstractMultiple sclerosis (MS) is characterized by inflammation, axonal and oligodendrocyte patholo...
A recent genome wide association study (GWAS) demonstrated that more than 100 genetic variants influ...
Genome-wide association studies (GWAS) have identified more than 50,000 unique associations with com...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Genome-wide association studies (GWAS) testing several hundred thousand SNPs have been performed in ...
Genome-wide association studies (GWASs) have proven highly effective, identifying hundreds of associ...
Genome-wide association studies (GWAS) have identified more than 50,000 unique associations with com...
Background: Multiple sclerosis (MS) is a complex trait in which genes in the MHC class II region ex...